Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 590703, 11 pages
http://dx.doi.org/10.1155/2013/590703
Research Article

In Vitro Antimicrobial Activity of Ethanolic Extract of Polish Propolis against Biofilm Forming Staphylococcus epidermidis Strains

1Department and Institute of Microbiology and Virology, School of Pharmacy and Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland
2Department and Institute of Pathology, School of Pharmacy and Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Poland
3Department of Conservative Dentistry with Endodontics, Medical University of Silesia, Katowice, Poland

Received 27 January 2013; Revised 20 March 2013; Accepted 20 March 2013

Academic Editor: José Maurício Sforcin

Copyright © 2013 Robert D. Wojtyczka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Rohde, M. A. Horstkotte, D. Mack, and J. K. M. Knobloch, “Coagulase-negative staphylococci,” in Biofilms, Infection, and Antimicrobial Therapy, J. L. Pace, M. E. Rupp, and R. G. Finch, Eds., chapter 7, pp. 109–153, CRC Press, New York, NY, USA, 2005. View at Google Scholar
  2. K. H. Schleifer and W. E. Kloos, “Isolation and characterization of staphylococci from human skin. I. Amended descriptions of Staphylococcus epidermidis and Staphylococcus saprophyticus and descriptions of three new species: Staphylococcus cohnii, Staphylococcus haemolyticus, and Staphylococcus xylosus,” International Journal of Systematic Bacteriology, vol. 25, no. 1, pp. 50–61, 1975. View at Google Scholar · View at Scopus
  3. J. Huebner and D. A. Goldmann, “Coagulase-negative staphylococci: role as pathogens,” Annual Review of Medicine, vol. 50, pp. 223–236, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. Shanson, “Staphylococcal infections in hospital,” The British Journal of Hospital Medicine, vol. 35, no. 5, pp. 312–320, 1986. View at Google Scholar · View at Scopus
  5. M. H. Grosserode and R. P. Wenzel, “The continuing importance of staphylococci as major hospital pathogens,” Journal of Hospital Infection, vol. 19, pp. 3–17, 1991. View at Google Scholar · View at Scopus
  6. J. O. Galdbart, J. Allignet, H. S. Tung, R. Cécilia, and N. El Solh, “Screening for Staphylococcus epidermidis markers discriminating between skin-flora strains and those responsible for infections of joint prostheses,” Journal of Infectious Diseases, vol. 182, no. 1, pp. 351–355, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Baniasadi, A. Dorudinia, M. Mobarhan, M. Karimi Gamishan, and F. Fahimi, “Microbial contamination of single- and multiple-dose vials after opening in a pulmonary teaching hospital,” Brazilian Journal of Infectious Diseases, vol. 17, no. 1, pp. 69–73, 2013. View at Publisher · View at Google Scholar
  8. R. A. Blum and K. A. Rodvold, “Recognition and importance of Staphylococcus epidermidis infections,” Clinical Pharmacy, vol. 6, no. 6, pp. 464–475, 1987. View at Google Scholar · View at Scopus
  9. J. Golus, M. Stankevic, R. Sawicki, R. Los, A. Malm, and G. Ginalska, “Quantitative analysis of biofilm formed on vascular prostheses by Staphylococcus epidermidis with different ica and aap genetic status,” International Journal of Artificial Organs, vol. 36, no. 2, pp. 105–112, 2013. View at Publisher · View at Google Scholar
  10. J. P. Porto, O. C. Mantese, A. Arantes, C. Freitas, P. P. G. Filho, and R. M. Ribas, “Nosocomial infections in a pediatric intensive care unit of a developing country: NHSN surveillance,” Journal of the Brazilian Society of Tropical Medicine, vol. 45, no. 4, pp. 475–479, 2012. View at Publisher · View at Google Scholar
  11. V. H. Chu, C. W. Woods, J. M. Miro et al., “Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis,” Clinical Infectious Diseases, vol. 46, no. 2, pp. 232–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Duah, “Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report,” Annals of Clinical Microbiology and Antimicrobials, vol. 9, article 9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. F. D. Lowy and S. M. Hammer, “Staphylococcus epidermidis infections,” Annals of Internal Medicine, vol. 99, no. 6, pp. 834–839, 1983. View at Google Scholar · View at Scopus
  14. E. Heikens, A. Fleer, A. Paauw, A. Florijn, and A. C. Fluit, “Comparison of genotypic and phenotypic methods for species-level identification of clinical isolates of coagulase-negative staphylococci,” Journal of Clinical Microbiology, vol. 43, no. 5, pp. 2286–2290, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Gaszewska-Mastalarz, M. Mordarski, and J. Zakrzewska-Czerwińska, “Diagnostic molecular microbiology—identification of Staphylococcus epidermidis,” Postępy Higieny i Medycyny Doświadczalnej, vol. 52, no. 1, pp. 19–34, 1998. View at Google Scholar · View at Scopus
  16. M. Drancourt and D. Raoult, “rpoB gene sequence-based identification of Staphylococcus species,” Journal of Clinical Microbiology, vol. 40, no. 4, pp. 1333–1338, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Ghebremedhin, F. Layer, W. König, and B. König, “Genetic classification and distinguishing of Staphylococcus species based on different partial gap, 16S rRNA, hsp60, rpoB, sodA, and tuf gene sequences,” Journal of Clinical Microbiology, vol. 46, no. 3, pp. 1019–1025, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Drago, B. Mombelli, E. de Vecchi, M. C. Fassina, L. Tocalli, and M. R. Gismondo, “In vitro antimicrobial activity of propolis dry extract,” Journal of Chemotherapy, vol. 12, no. 5, pp. 390–395, 2000. View at Google Scholar · View at Scopus
  19. W. Król, S. Scheller, Z. Czuba et al., “Inhibition of neutrophils' chemiluminescence by ethanol extract of propolis (EEP) and its phenolic components,” Journal of Ethnopharmacology, vol. 55, no. 1, pp. 19–25, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Szliszka, G. Zydowicz, B. Janoszka, C. Dobosz, G. Kowalczyk-Ziomek, and W. Król, “Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis,” International Journal of Oncology, vol. 38, no. 4, pp. 941–953, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Szliszka, Z. P. Czuba, J. Bronikowska, A. Mertas, A. Paradysz, and W. Król, “Ethanolic extract of propolis (EEP) augments TRAIL-induced apoptotic death in prostate cancer cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 535172, 11 pages, 2011. View at Publisher · View at Google Scholar
  22. E. W. Teixeira, G. Negri, R. M. S. A. Meira, D. Message, and A. Salatino, “Plant origin of green propolis: cee behavior, plant anatomy and chemistry,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 1, pp. 85–92, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. C. H. F. Sawaya, K. S. Souza, M. C. Marcucci, I. B. S. Cunha, and M. T. Shimizu, “Analysis of the composition of Brazilian propolis extracts by chromatography and evaluation of their in vitro activity against gram-positive bacteria,” Brazilian Journal of Microbiology, vol. 35, no. 1-2, pp. 104–109, 2004. View at Google Scholar · View at Scopus
  24. V. Bankova, R. Christov, A. Kujumgiev, M. C. Marcucci, and S. Popov, “Chemical composition and antibacterial activity of Brazilian propolis,” Zeitschrift fur Naturforschung C, vol. 50, no. 3-4, pp. 167–172, 1995. View at Google Scholar · View at Scopus
  25. A. G. Hegazi, F. K. Abd El Hady, and F. A. M. Abd Allah, “Chemical composition and antimicrobial activity of European propolis,” Zeitschrift fur Naturforschung C, vol. 55, no. 1-2, pp. 70–75, 2000. View at Google Scholar · View at Scopus
  26. W. Król, S. Scheller, J. Shani, G. Pietsz, and Z. Czuba, “Synergistic effect of ethanolic extract of propolis and antibiotics on the growth of Staphylococcus aureus,” Arzneimittel-Forschung, vol. 43, no. 5, pp. 607–609, 1993. View at Google Scholar · View at Scopus
  27. A. Kujumgiev, I. Tsvetkova, Y. Serkedjieva, V. Bankova, R. Christov, and S. Popov, “Antibacterial, antifungal and antiviral activity of propolis of different geographic origin,” Journal of Ethnopharmacology, vol. 64, no. 3, pp. 235–240, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. J. M. Sforcin, A. Fernandes, C. A. M. Lopes, V. Bankova, and S. R. C. Funari, “Seasonal effect on Brazilian propolis antibacterial activity,” Journal of Ethnopharmacology, vol. 73, no. 1-2, pp. 243–249, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. G. P. S. R. Rezende, F. C. Pimenta, and L. R. R. S. Costa, “Antimicrobial activity of two Brazilian commercial propolis extracts,” Brazilian Journal of Oral Sciences, vol. 5, no. 16, pp. 967–970, 2006. View at Google Scholar
  30. N. AL-Waili, A. Al-Ghamdi, M. J. Ansari, Y. Al-Attal, and K. Salom, “Synergistic effects of honey and propolis toward drug multi-resistant Staphylococcus aureus, Escherichia coli and Candida albicans isolates in single and polymicrobial cultures,” International Journal of Medical Sciences, vol. 9, no. 9, pp. 793–800, 2012. View at Publisher · View at Google Scholar
  31. Y. Onlen, N. Duran, E. Atik et al., “Antibacterial activity of propolis against MRSA and synergism with topical mupirocin,” Journal of Alternative and Complementary Medicine, vol. 13, no. 7, pp. 713–718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Y. Queck and M. Otto, “Staphylococcus epidermidis and other coagulase-negative staphylococci,” in Staphylococcus: Molecular Genetics, Caister Academic Press, Norfolk, UK, 2008. View at Google Scholar
  33. S. Sugimoto, T. Iwamoto, K. Takada et al., “Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction,” Journal of Bacteriology, 2013. View at Publisher · View at Google Scholar
  34. S. R. Gill, D. E. Fouts, G. L. Archer et al., “Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain,” Journal of Bacteriology, vol. 187, no. 7, pp. 2426–2438, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. M. Shah, H. Iihara, M. Noda et al., “dnaJ gene sequence-based assay for species identification and phylogenetic grouping in the genus Staphylococcus,” International Journal of Systematic and Evolutionary Microbiology, vol. 57, no. 1, pp. 25–30, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Hauschild and S. Stepanović, “Identification of Staphylococcus spp. by PCR-restriction fragment length polymorphism analysis of dnaJ gene,” Journal of Clinical Microbiology, vol. 46, no. 12, pp. 3875–3879, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Ziebuhr, V. Krimmer, S. Rachid, I. Lößner, F. Götz, and J. Hacker, “A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256,” Molecular Microbiology, vol. 32, no. 2, pp. 345–356, 1999. View at Google Scholar · View at Scopus
  38. G. D. I. de Silva, M. Kantzanou, A. Justice et al., “The ica operon and biofilm production in coagulase-negative staphylococci associated with carriage and disease in a neonatal intensive care unit,” Journal of Clinical Microbiology, vol. 40, no. 2, pp. 382–388, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. G. D. Christensen, W. A. Simpson, J. J. Younger et al., “Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices,” Journal of Clinical Microbiology, vol. 22, no. 6, pp. 996–1006, 1985. View at Google Scholar · View at Scopus
  40. D. Amsterdam, “Susceptibility testing of antimicrobials in liquid media,” in Antibiotics in Laboratory Medicine, V. Loman, Ed., pp. 61–143, Williams & Wilkins, Philadelphia, Pa, USA, 5th edition, 2005. View at Google Scholar
  41. “European committee for antimicrobial susceptibility testing (EUCAST) of the european society of clinical microbiology and infectious diseases (ESCMID) determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. EUCAST discussion document E.dis. 5.1,” Clinical Microbiology and Infection, vol. 9, no. 8, pp. 1–7, 2003.
  42. M. Cudic, B. A. Condie, D. J. Weiner et al., “Development of novel antibacterial peptides that kill resistant isolates,” Peptides, vol. 23, no. 12, pp. 2071–2083, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. K. F. Devienne and M. S. G. Raddi, “Screening for antimicrobial activity of natural products using a microplate photometer,” Brazilian Journal of Microbiology, vol. 33, no. 2, pp. 166–168, 2002. View at Google Scholar · View at Scopus
  44. S. Schwarz, P. Silley, S. Simjee et al., “Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 4, pp. 601–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. R. K. Pettit, C. A. Weber, M. J. Kean et al., “Microplate alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 7, pp. 2612–2617, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. R. P. Mantovani, V. L. M. Rall, J. E. N. Batalha, A. A. H. Fernandes, and A. Fernandes, “Anti-coagulase-negative Staphylococcus activity of ethanolic extracts of propolis from two Brazilian regions and synergism with antimicrobial drugs by the E-test method,” Journal of Venomous Animals and Toxins Including Tropical Diseases, vol. 14, no. 2, pp. 357–365, 2008. View at Google Scholar · View at Scopus
  47. H. H. Najmadeen and F. A. K. Kakamand, “Antimicrobial activity of propolis collected in different regions of Sulaimani province-Kurdistan region/Iraq,” Journal of Duhok University, vol. 12, no. 1, pp. 233–239, 2009. View at Google Scholar
  48. J. Stojko, R. D. Wojtyczka, A. Kabała-Dzik, R. Stojko, M. Kępa, and A. Moździerz, “Comparative studies on the antimicrobial activity of apitherapeutics applied to experimental burn wounds,” Polish Journal of Environmental Study, vol. 16, no. 2, pp. 612–615, 2007. View at Google Scholar
  49. A. L. Orozco, J. G. A. Acevedo, M. M. C. Martinez et al., “Antibacterial comparative study between extracts of mexican propolis and of three plants which use Apis mellifera for its production,” Journal of Animal and Veterinary Advances, vol. 9, no. 8, pp. 1250–1254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. M. S. Pinto, J. E. Faria, D. Message, S. T. A. Cassini, C. S. Pereira, and M. M. Gioso, “Effect of green propolis extracts on patogenic bacteria isolated from milk of cows with mastitis,” Brazilian Journal of Veterinary Research and Animal Science, vol. 38, no. 6, pp. 278–283, 2001. View at Publisher · View at Google Scholar
  51. A. A. Berretta, A. P. Nascimento, P. C. Bueno, M. M. de Oliveira Lima Leite Vaz, and J. M. Marchetti, “Propolis standardized extract (EPP-AF), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds,” International Journal of Biological Sciences, vol. 8, no. 4, pp. 512–521, 2012. View at Publisher · View at Google Scholar
  52. H. Oksuz, N. Duran, C. Tamer, M. Cetin, and S. Silici, “Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits,” Ophthalmic Research, vol. 37, no. 6, pp. 328–334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Havsteen, “Flavonoids, a class of natural products of high pharmacological potency,” Biochemical Pharmacology, vol. 32, no. 7, pp. 1141–1148, 1983. View at Publisher · View at Google Scholar · View at Scopus
  54. O. K. Mirzoeva, R. N. Grishanin, and P. C. Calder, “Antimicrobial action of propolis and some of its components: the effects on growth, membrane potential and motility of bacteria,” Microbiological Research, vol. 152, no. 3, pp. 239–246, 1997. View at Google Scholar · View at Scopus
  55. N. B. Takaisi-Kikuni and H. Schilcher, “Electron microscopic and microcalorimetric investigations of the possible mechanism of the antibacterial action of a defined propolis provenance,” Planta Medica, vol. 60, no. 3, pp. 222–227, 1994. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Borrelli, P. Maffia, L. Pinto et al., “Phytochemical compounds involved in the anti-inflammatory effect of propolis extract,” Fitoterapia, vol. 73, supplement 1, pp. S53–S63, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. P. S. Stewart and J. W. Costerton, “Antibiotic resistance of bacteria in biofilms,” The Lancet, vol. 358, no. 9276, pp. 135–138, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Raghukumar, L. Vali, D. Watson, J. Fearnley, and V. Seidel, “Antimethicillin-resistant Staphylococcus aureus (MRSA) activity of “pacific propolis” and isolated prenylflavanones,” Phytotherapy Research, vol. 24, no. 8, pp. 1181–1187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. R. O. Orsi, A. Fernandes, V. Bankova, and J. M. Sforcin, “The effects of Brazilian and Bulgarian propolis in vitro against Salmonella Typhi and their synergism with antibiotics acting on the ribosome,” Natural Product Research, vol. 26, no. 5, pp. 430–437, 2012. View at Publisher · View at Google Scholar
  60. S. Stepanović, N. Antić, I. Dakić, and M. Švabić-Vlahović, “In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs,” Microbiological Research, vol. 158, no. 4, pp. 353–357, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Fernandes Jr., E. C. Balestrin, J. E. C. Betoni, R. de Oliveira Orsi, M. D. L. R. de Souza da Cunha, and A. C. Montelli, “Propolis: anti-Staphylococcus aureus activity and synergism with antimicrobial drugs,” Memórias do Instituto Oswaldo Cruz, vol. 100, no. 5, pp. 563–566, 2005. View at Google Scholar · View at Scopus